{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:07:41Z","timestamp":1784038061331,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173900"],"award-info":[{"award-number":["82173900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Children\u2019s Hospital Talent Introduction Start up Project","award":["SHSETYY20250505"],"award-info":[{"award-number":["SHSETYY20250505"]}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR4072"],"award-info":[{"award-number":["SHDC2020CR4072"]}]},{"name":"2022 Shanghai Young Pharmaceutical Talent Ability Enhancement Project","award":["HYHZ (2023) No. 04"],"award-info":[{"award-number":["HYHZ (2023) No. 04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-026-02117-z","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:58:06Z","timestamp":1773817086000},"page":"1390-1400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABCC2 rs2273697 is an independent determinant of tacrolimus intra-patient variability during the first year after kidney transplantation"],"prefix":"10.1007","volume":"48","author":[{"given":"Jia","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaZhao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2117_CR1","doi-asserted-by":"publisher","first-page":"979983","DOI":"10.3389\/fimmu.2022.979983","volume":"13","author":"Z Tang","year":"2022","unstructured":"Tang Z, Li T, Dai H, et al. Drug-induced fanconi syndrome in patients with kidney allograft transplantation. Front Immunol. 2022;13:979983. https:\/\/doi.org\/10.3389\/fimmu.2022.979983.","journal-title":"Front Immunol"},{"issue":"12","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1111\/ajt.15952","volume":"20","author":"K Yu","year":"2020","unstructured":"Yu K, King K, Husain SA, et al. Kidney nonprocurement in solid organ donors in the United States. Am J Transplant. 2020;20(12):3413\u201325. https:\/\/doi.org\/10.1111\/ajt.15952.","journal-title":"Am J Transplant"},{"key":"2117_CR3","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3390\/ijms21082976","volume":"21","author":"M Zhang","year":"2020","unstructured":"Zhang M, Tajima S, Shigematsu T, et al. Donor CYP3A5 gene polymorphism alone cannot predict tacrolimus intrarenal concentration in renal transplant recipients. Int J Mol Sci. 2020;21:2976. https:\/\/doi.org\/10.3390\/ijms21082976.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajps.2018.08.001","volume":"14","author":"H Xu","year":"2019","unstructured":"Xu H, Liu L, Li X, et al. Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets. Asian J Pharm Sci. 2019;14(4):445\u201354. https:\/\/doi.org\/10.1016\/j.ajps.2018.08.001.","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"2117_CR5","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.3346\/jkms.2022.37.e33","volume":"37","author":"SM Kim","year":"2022","unstructured":"Kim SM, Lim Y, Min S, et al. Flat pattern peaks of tacrolimus absorption and associated pharmacogenomic variants in kidney transplantation recipients. J Korean Med Sci. 2022;37(5):e33. https:\/\/doi.org\/10.3346\/jkms.2022.37.e33.","journal-title":"J Korean Med Sci"},{"key":"2117_CR6","doi-asserted-by":"publisher","first-page":"636048","DOI":"10.3389\/fphar.2021.636048","volume":"12","author":"P Fontova","year":"2021","unstructured":"Fontova P, Colom H, Rigo-Bonnin R, et al. Influence of the circadian timing system on tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation. Front Pharmacol. 2021;12:636048. https:\/\/doi.org\/10.3389\/fphar.2021.636048.","journal-title":"Front Pharmacol"},{"key":"2117_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061247","author":"S De Gregori","year":"2022","unstructured":"De Gregori S, De Silvestri A, Cattadori B, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy in heart transplantation: new strategies and preliminary results in endomyocardial biopsies. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061247.","journal-title":"Pharmaceutics"},{"key":"2117_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.674117","volume":"12","author":"S Contreras-Castillo","year":"2021","unstructured":"Contreras-Castillo S, Plaza A, Stojanova J, et al. Effect of CYP3A4, CYP3A5, MDR1 and POR genetic polymorphisms in immunosuppressive treatment in Chilean kidney transplanted patients. Front Pharmacol. 2021;12:674117. https:\/\/doi.org\/10.3389\/fphar.2021.674117.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2117_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","volume":"31","author":"P Wallemacq","year":"2009","unstructured":"Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31(2):139\u201352. https:\/\/doi.org\/10.1097\/FTD.0b013e318198d092.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2117_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2015.01.002","volume":"29","author":"N Shuker","year":"2015","unstructured":"Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. Transplant Rev (Orlando). 2015;29(2):78\u201384. https:\/\/doi.org\/10.1016\/j.trre.2015.01.002.","journal-title":"Transplant Rev (Orlando)"},{"issue":"2","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/cpt.1618","volume":"107","author":"DRJ Kuypers","year":"2020","unstructured":"Kuypers DRJ. Intrapatient variability of tacrolimus exposure in solid organ transplantation: a novel marker for clinical outcome. Clin Pharmacol Ther. 2020;107(2):347\u201358. https:\/\/doi.org\/10.1002\/cpt.1618.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/phar.2480","volume":"41","author":"L Schumacher","year":"2021","unstructured":"Schumacher L, Leino AD, Park JM. Tacrolimus intrapatient variability in solid organ transplantation: a multiorgan perspective. Pharmacotherapy. 2021;41(1):103\u201318. https:\/\/doi.org\/10.1002\/phar.2480.","journal-title":"Pharmacotherapy"},{"key":"2117_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216320","author":"A Nuchjumroon","year":"2022","unstructured":"Nuchjumroon A, Vadcharavivad S, Singhan W, et al. Comparison of tacrolimus intra-patient variability during 6-12 months after kidney transplantation between CYP3A5 expressers and nonexpressers. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11216320.","journal-title":"J Clin Med"},{"issue":"6","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/10600280231197399","volume":"58","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Du Y, Ren S, et al. CYP3A5 genotype-dependent drug-drug interaction between tacrolimus and voriconazole in Chinese kidney transplant patients. Ann Pharmacother. 2024;58(6):605\u201313. https:\/\/doi.org\/10.1177\/10600280231197399.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"2117_CR15","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/aps.2016.77","volume":"37","author":"S Liu","year":"2016","unstructured":"Liu S, Chen RX, Li J, et al. The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients. Acta Pharmacol Sin. 2016;37(9):1251\u20138. https:\/\/doi.org\/10.1038\/aps.2016.77.","journal-title":"Acta Pharmacol Sin"},{"key":"2117_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw083","author":"K Toth","year":"2016","unstructured":"Toth K, Csukly G, Sirok D, et al. Optimization of clonazepam therapy adjusted to patient\u2019s CYP3A status and NAT2 genotype. Int J Neuropsychopharmacol. 2016. https:\/\/doi.org\/10.1093\/ijnp\/pyw083.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2117_CR17","doi-asserted-by":"publisher","first-page":"869554","DOI":"10.3389\/fimmu.2022.869554","volume":"13","author":"E Crespo","year":"2022","unstructured":"Crespo E, Vidal-Alabro A, Jouve T, et al. Tacrolimus CYP3A single-nucleotide polymorphisms and preformed T- and B-cell alloimmune memory improve current pretransplant rejection-risk stratification in kidney transplantation. Front Immunol. 2022;13:869554. https:\/\/doi.org\/10.3389\/fimmu.2022.869554.","journal-title":"Front Immunol"},{"issue":"9","key":"2117_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40262-013-0069-2","volume":"52","author":"K Ogasawara","year":"2013","unstructured":"Ogasawara K, Chitnis SD, Gohh RY, et al. Multidrug resistance-associated protein 2 (MRP2\/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clin Pharmacokinet. 2013;52(9):751\u201362. https:\/\/doi.org\/10.1007\/s40262-013-0069-2.","journal-title":"Clin Pharmacokinet"},{"key":"2117_CR19","doi-asserted-by":"publisher","first-page":"1701027","DOI":"10.1002\/adfm.201701027","volume":"27","author":"R Zhang","year":"2017","unstructured":"Zhang R, Gao S, Wang Z, et al. Multifunctional molecular beacon micelles for intracellular mRNA imaging and synergistic therapy in multidrug-resistant cancer cells. Adv Funct Mater. 2017;27:1701027. https:\/\/doi.org\/10.1002\/adfm.201701027.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"2117_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/jpm14040440","volume":"14","author":"CL Choong","year":"2024","unstructured":"Choong CL, Islahudin F, Wong HS, et al. The impact of ABCC2 -24C>T gene polymorphism on graft survival in kidney transplant recipients. J Pers Med. 2024;14(4):440. https:\/\/doi.org\/10.3390\/jpm14040440.","journal-title":"J Pers Med."},{"issue":"4","key":"2117_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247\u201354. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2215\/CJN.16421221","volume":"17","author":"KH Piburn","year":"2022","unstructured":"Piburn KH, Sigurjonsdottir VK, Indridason OS, et al. Patterns in tacrolimus variability and association with de novo donor-specific antibody formation in pediatric kidney transplant recipients. Clin J Am Soc Nephrol. 2022;17(8):1194\u2013203. https:\/\/doi.org\/10.2215\/CJN.16421221.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"2117_CR23","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1111\/ajt.15385","volume":"19","author":"ME Mohamed","year":"2019","unstructured":"Mohamed ME, Schladt DP, Guan W, et al. Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: a comparison of four ancestry groups. Am J Transplant. 2019;19(10):2795\u2013804. https:\/\/doi.org\/10.1111\/ajt.15385.","journal-title":"Am J Transplant"},{"key":"2117_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/PGPM.S107710","volume":"11","author":"L Chen","year":"2018","unstructured":"Chen L, Prasad GVR. CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment. Pharmacogenomics Pers Med. 2018;11:23\u201333. https:\/\/doi.org\/10.2147\/PGPM.S107710.","journal-title":"Pharmacogenomics Pers Med"},{"issue":"4","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.arcmed.2012.05.005","volume":"43","author":"P Garcia-Roca","year":"2012","unstructured":"Garcia-Roca P, Medeiros M, Reyes H, et al. CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing. Arch Med Res. 2012;43(4):283\u20137. https:\/\/doi.org\/10.1016\/j.arcmed.2012.05.005.","journal-title":"Arch Med Res"},{"issue":"10","key":"2117_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.542","volume":"11","author":"L Huang","year":"2021","unstructured":"Huang L, Assiri AA, Wen P, et al. The CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantation. Clin Transl Med. 2021;11(10):e542. https:\/\/doi.org\/10.1002\/ctm2.542.","journal-title":"Clin Transl Med"},{"issue":"4","key":"2117_CR27","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v15.i4.107636","volume":"15","author":"AS Pasari","year":"2025","unstructured":"Pasari AS, Malde S, Tolani P, et al. Impact of cytochrome P450 3A5 expression on clinical outcomes in renal transplant recipients receiving tacrolimus-based immunosuppression. World J Transplant. 2025;15(4):107636. https:\/\/doi.org\/10.5500\/wjt.v15.i4.107636.","journal-title":"World J Transplant"},{"key":"2117_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/pharmaceutics14020354","volume":"14","author":"L Sendra","year":"2022","unstructured":"Sendra L, Olivera GG, Lopez-Andujar R, et al. Pharmacogene variants associated with liver transplant in a twelve-year clinical follow-up. Pharmaceutics. 2022;14:354. https:\/\/doi.org\/10.3390\/pharmaceutics14020354.","journal-title":"Pharmaceutics"},{"key":"2117_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/pharmaceutics14061289","volume":"14","author":"R Tilen","year":"2022","unstructured":"Tilen R, Paioni P, Goetschi AN, et al. Pharmacogenetic analysis of voriconazole treatment in children. Pharmaceutics. 2022;14:1289. https:\/\/doi.org\/10.3390\/pharmaceutics14061289.","journal-title":"Pharmaceutics"},{"key":"2117_CR30","doi-asserted-by":"publisher","first-page":"104971","DOI":"10.1016\/j.compbiomed.2021.104971","volume":"139","author":"H Mallina","year":"2021","unstructured":"Mallina H, Elumalai R, Fdp S, et al. Computational validation of ABCB1 gene polymorphism and its effect on tacrolimus dose concentration\/levels in renal transplant individuals of South India. Comput Biol Med. 2021;139:104971. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104971.","journal-title":"Comput Biol Med"},{"issue":"10","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.clinthera.2020.07.016","volume":"42","author":"W Peng","year":"2020","unstructured":"Peng W, Lin Y, Zhang H, et al. Effect of ABCB1 3435C&gt;T genetic polymorphism on pharmacokinetic variables of tacrolimus in adult renal transplant recipients: a systematic review and meta-analysis. Clin Ther. 2020;42(10):2049\u201365. https:\/\/doi.org\/10.1016\/j.clinthera.2020.07.016.","journal-title":"Clin Ther"},{"key":"2117_CR32","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2147\/PGPM.S337947","volume":"14","author":"F Cheng","year":"2021","unstructured":"Cheng F, Li Q, Wang J, et al. Genetic polymorphisms affecting tacrolimus metabolism and the relationship to post-transplant outcomes in kidney transplant recipients. Pharmacogenomics Pers Med. 2021;14:1463\u201374. https:\/\/doi.org\/10.2147\/PGPM.S337947.","journal-title":"Pharmacogenomics Pers Med"},{"key":"2117_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3129389","volume":"2022","author":"F Cheng","year":"2022","unstructured":"Cheng F, Li Q, Cui Z, et al. Tacrolimus concentration is effectively predicted using combined clinical and genetic factors in the perioperative period of kidney transplantation and associated with acute rejection. J Immunol Res. 2022;2022:3129389. https:\/\/doi.org\/10.1155\/2022\/3129389.","journal-title":"J Immunol Res"},{"key":"2117_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.973564","volume":"13","author":"B Kostalova","year":"2022","unstructured":"Kostalova B, Mala-Ladova K, Sulkova SD, et al. Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence. Front Pharmacol. 2022;13:973564. https:\/\/doi.org\/10.3389\/fphar.2022.973564.","journal-title":"Front Pharmacol"},{"key":"2117_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1622702","volume":"16","author":"J You","year":"2025","unstructured":"You J, Chen R, Chai Y, et al. Comparing tacrolimus level monitoring in peripheral blood mononuclear cells and whole blood within one year after kidney transplantation: a single-center, prospective, observational study. Front Pharmacol. 2025;16:1622702. https:\/\/doi.org\/10.3389\/fphar.2025.1622702.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2117_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4174\/astr.2025.109.4.252","volume":"109","author":"SO Gongor","year":"2025","unstructured":"Gongor SO, Lee KW, Choi EW, et al. Single-nucleotide polymorphisms of donor CYP3A5 and recipient ABCB1 affect tacrolimus intrapatient variability in living donor liver transplantation: a retrospective cohort study. Ann Surg Treat Res. 2025;109(4):252\u201360. https:\/\/doi.org\/10.4174\/astr.2025.109.4.252.","journal-title":"Ann Surg Treat Res"},{"issue":"6","key":"2117_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14297","volume":"26","author":"JS Choi","year":"2022","unstructured":"Choi JS, Ko H, Kim HK, et al. Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation. Pediatr Transplant. 2022;26(6):e14297. https:\/\/doi.org\/10.1111\/petr.14297.","journal-title":"Pediatr Transplant"},{"issue":"6","key":"2117_CR38","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.transproceed.2019.04.019","volume":"51","author":"CY Cheung","year":"2019","unstructured":"Cheung CY, Chan KM, Wong YT, et al. Impact of CYP3A5 genetic polymorphism on intrapatient variability of tacrolimus exposure in Chinese kidney transplant recipients. Transplant Proc. 2019;51(6):1754\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.019.","journal-title":"Transplant Proc"},{"issue":"1","key":"2117_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-025-02231-3","volume":"18","author":"Y Chai","year":"2025","unstructured":"Chai Y, Hu L, Zhu Y, et al. Association of CYP3A5 rs15524 and CYP3A7 rs776744 polymorphisms on tac IPV and clinical outcomes in early post-heart transplantation. BMC Med Genomics. 2025;18(1):151. https:\/\/doi.org\/10.1186\/s12920-025-02231-3.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"2117_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13318-025-00955-2","volume":"50","author":"Z Kaltus","year":"2025","unstructured":"Kaltus Z, Harmanci N, Sahin G, et al. Association of CYP3A5, ABCB1, and CYP2C8 polymorphisms with renal function in kidney transplant recipients receiving tacrolimus. Eur J Drug Metab Pharmacokinet. 2025;50(5):383\u201397. https:\/\/doi.org\/10.1007\/s13318-025-00955-2.","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02117-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02117-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02117-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:31:09Z","timestamp":1784035869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02117-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02117-z","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study protocol was approved by the Ethics Committee of the Shanghai Changhai Hospital (CHEC2021-133, approval date 2021-08-28).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}